Botfet / Company detail

VRTX

universe

Vertex Pharmaceuticals

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic18.1%

Gross Margin85.0%

Revenue Cagr12.4%

Fcf Conversion80.8%

Fcf Yield2.5%

Interest Coverage365.9x

Market Cap B$130.2B

Pe30.3

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener